Back

Appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischemic and non-ischemic cardiomyopathy

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Implantable cardioverter defibrillators: technology and complications Cardioversion and Defibrillation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Gustav Mattsson

Uppsala University, Gavle (Sweden)

7 More presentations in this session

Presentation thumbnail
Mr S. Varghese (Halberstadt, DE)
Abstract Slides
Presentation thumbnail
Doctor G. Fernandez (Mainz, DE)
Abstract Slides
Presentation thumbnail
Doctor R. Kader (Gävle, SE)
Abstract Slides
Presentation thumbnail
Mr K. Siejko (St. Paul MN, US)
Abstract Slides
Presentation thumbnail
Doctor F. Ayala Paredes (Sherbrooke, CA)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Implantable cardioverter defibrillators: technology and complications

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Ten-year follow-up of implantable cardioverter-defibrillator device implantation in non-ischaemic cardiomyopathy - an insight from real world practice in a large district general hospital.
27 August 2021
thumbnail
Congress Session
Navigating through heart failure device therapies
18 May 2025
thumbnail
Congress Presentation
Periodic Repolarization Dynamics (PRD) identifies patients who profit from ICD implantation, A meta-analysis of the predictive value of PRD
27 August 2023
thumbnail
Congress Presentation
Cost-effectiveness of implantable cardioverter defibrillator for the primary prevention of sudden death
1 July 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources